We came across a 72-year-old man, who presented with oral intolerance to spicy food with raw areas over the lips and oral cavity and ulcers over pre-existing psoriatic plaques for the last 6 days. Detailed history revealed that he had taken daily doses of methotrexate (MTX) 7.5 mg twice a day without folic acid for 4 days (cumulative dose of 60 mg), the last dose taken 72 hours before presenting to us; without any proper prescription or instructions by a local practitioner. On examination, he had multiple erosions with haemorrhagic crusts on the lower lip and buccal mucosa (fig. 1) along with erythematous scaly plaques with partially healed ulcers over the extensor aspect of bilateral extremities (PASI 10.2) (fig. 2).A provisional diagnosis...
Psoriatic plaque erosion is a rare toxic side effect of low-dose methotrexate (LDMTX) that has been...
Pancytopenia is a rare but serious adverse effect of low-dose methotrexate (MTX) sodium therapy, and...
Methotrexate (MTX) is an antimetabolite which competitively inhibits dihydrofolic acid reductase; in...
Methotrexate, a folic acid analogue is being used globally in the treatment of neoplastic diseases a...
Abstract: Methotrexate is one of the most used drugs in the treatment of psoriasis with indication o...
Methotrexate (MTX) is an effective but potentially toxic treatment for psoriasis. We describe a pati...
Methotrexate is an antimetabolite analog to folic acid that competitively inhibits the enzyme dihydr...
The prescription of Methotrexate is well-recognized for various neoplastic diseases. For Rheumatoid ...
Methotrexate (MTX) is an immunomodulating agent used in many autoimmune diseases. Its toxicity is do...
We describe two cases of methotrexate toxicity occurring due to inappropriate self-medication with t...
A 71-year-old male was referred from his general practitioner to the Oral Medicine Clinic at the Un...
The Author(s) 2014. This article is published with open access at Springerlink.com Methotrexate cont...
Methotrexate-induced cutaneous ulceration is a rare but potentially serious drug adverse reaction. T...
Methotrexate (MTX) has an antiproliferative, anti-inflammatory, immunomodulatory, and immunosuppress...
Methotrexate (MTX) is an antimetabolite which interferes with DNA synthesis. It is used for the trea...
Psoriatic plaque erosion is a rare toxic side effect of low-dose methotrexate (LDMTX) that has been...
Pancytopenia is a rare but serious adverse effect of low-dose methotrexate (MTX) sodium therapy, and...
Methotrexate (MTX) is an antimetabolite which competitively inhibits dihydrofolic acid reductase; in...
Methotrexate, a folic acid analogue is being used globally in the treatment of neoplastic diseases a...
Abstract: Methotrexate is one of the most used drugs in the treatment of psoriasis with indication o...
Methotrexate (MTX) is an effective but potentially toxic treatment for psoriasis. We describe a pati...
Methotrexate is an antimetabolite analog to folic acid that competitively inhibits the enzyme dihydr...
The prescription of Methotrexate is well-recognized for various neoplastic diseases. For Rheumatoid ...
Methotrexate (MTX) is an immunomodulating agent used in many autoimmune diseases. Its toxicity is do...
We describe two cases of methotrexate toxicity occurring due to inappropriate self-medication with t...
A 71-year-old male was referred from his general practitioner to the Oral Medicine Clinic at the Un...
The Author(s) 2014. This article is published with open access at Springerlink.com Methotrexate cont...
Methotrexate-induced cutaneous ulceration is a rare but potentially serious drug adverse reaction. T...
Methotrexate (MTX) has an antiproliferative, anti-inflammatory, immunomodulatory, and immunosuppress...
Methotrexate (MTX) is an antimetabolite which interferes with DNA synthesis. It is used for the trea...
Psoriatic plaque erosion is a rare toxic side effect of low-dose methotrexate (LDMTX) that has been...
Pancytopenia is a rare but serious adverse effect of low-dose methotrexate (MTX) sodium therapy, and...
Methotrexate (MTX) is an antimetabolite which competitively inhibits dihydrofolic acid reductase; in...